National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials

BackgroundA recent WHO review concluded that live BCG and measles vaccine (MV) may have beneficial non-specific effects (NSEs) reducing mortality from non-targeted diseases. NSEs of oral polio vaccine (OPV) were not examined. If OPV vaccination campaigns reduce the mortality rate, it would suggest b...

Full description

Saved in:
Bibliographic Details
Main Authors: Andreas Andersen (Author), Ane Baerent Fisker (Author), Amabelia Rodrigues (Author), Cesario Martins (Author), Henrik Ravn (Author), Najaaraq Lund (Author), Sofie Biering-Sørensen (Author), Christine Stabell Benn (Author), Peter Aaby (Author)
Format: Book
Published: Frontiers Media S.A., 2018-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e4cb64eea95245ada4a8b44aea34dba5
042 |a dc 
100 1 0 |a Andreas Andersen  |e author 
700 1 0 |a Ane Baerent Fisker  |e author 
700 1 0 |a Amabelia Rodrigues  |e author 
700 1 0 |a Cesario Martins  |e author 
700 1 0 |a Henrik Ravn  |e author 
700 1 0 |a Henrik Ravn  |e author 
700 1 0 |a Najaaraq Lund  |e author 
700 1 0 |a Sofie Biering-Sørensen  |e author 
700 1 0 |a Christine Stabell Benn  |e author 
700 1 0 |a Christine Stabell Benn  |e author 
700 1 0 |a Peter Aaby  |e author 
700 1 0 |a Peter Aaby  |e author 
700 1 0 |a Peter Aaby  |e author 
245 0 0 |a National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials 
260 |b Frontiers Media S.A.,   |c 2018-02-01T00:00:00Z. 
500 |a 2296-2565 
500 |a 10.3389/fpubh.2018.00013 
520 |a BackgroundA recent WHO review concluded that live BCG and measles vaccine (MV) may have beneficial non-specific effects (NSEs) reducing mortality from non-targeted diseases. NSEs of oral polio vaccine (OPV) were not examined. If OPV vaccination campaigns reduce the mortality rate, it would suggest beneficial NSEs.SettingBetween 2002 and 2014, Guinea-Bissau had 15 general OPV campaigns and other campaigns with OPV plus vitamin A supplementation (VAS), VAS-only, MV, and H1N1 vaccine. In this period, we conducted seven randomized controlled trials (RCTs) with mortality as main outcome.MethodsWithin these RCTs, we assessed whether the mortality rate was lower after-campaign than before-campaign. We used Cox models with age as underlying time and further adjusted for low birth-weight, season and time trend in mortality. We calculated the adjusted mortality rate ratio (MRR) for after-campaign vs before-campaign.ResultsThe mortality rate was lower after OPV-only campaigns than before, the MRR being 0.81 (95% CI = 0.68-0.95). With each additional dose of campaign-OPV the mortality rate declined further (MRR = 0.87 (95% CI: 0.79-0.96) per dose) (test for trend, p = 0.005). No other type of campaign had similar beneficial effects. Depending on initial age and with follow-up to 3 years of age, the number needed to treat with campaign-OPV-only to save one life was between 68 and 230 children.ConclusionBissau had no case of polio infection so the results suggest that campaign-OPV has beneficial NSEs. Discontinuation of OPV-campaigns in low-income countries may affect general child mortality levels negatively. 
546 |a EN 
690 |a campaigns 
690 |a child mortality 
690 |a MDG4 
690 |a oral polio vaccine 
690 |a non-specific effects of vaccines 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Frontiers in Public Health, Vol 6 (2018) 
787 0 |n http://journal.frontiersin.org/article/10.3389/fpubh.2018.00013/full 
787 0 |n https://doaj.org/toc/2296-2565 
856 4 1 |u https://doaj.org/article/e4cb64eea95245ada4a8b44aea34dba5  |z Connect to this object online.